In June 2025, a delegation from Munich Clinic Bogenhausen—one of Southern Germany’s top teaching hospitals—visited China to explore clinical collaboration with Surgerii Robotics. Led by Prof. Johannes Bodner and Prof. Ayman Agha, the team engaged in hands-on training and live surgical observation with the SHURUI® single-port surgical robot at Ruijin Hospital, Shanghai.
The visit highlighted the SHURUI® system’s strengths in flexibility, multi-instrument synergy, and ultra-minimally invasive precision across general, thoracic, and urologic procedures. Experts from both countries exchanged insights on robotic surgery strategy, training models, and clinical outcomes.
This marks a key milestone in Surgerii Robotics’ international expansion. Joint plans are underway to initiate clinical trials in Germany, aiming to bring Chinese surgical innovation to European operating rooms. The collaboration exemplifies how global partnerships can advance the future of single-port robotic surgery—bridging continents through shared expertise and next-generation technology.
Important Notes
The Single-port Endoscopic Surgical System (SR-ENS-600), developed and produced by Beijing Surgerii Robotics Company Limited, has been approved by the National Medical Products Administration (NMPA) in China for urology and gynecology laparoscopic surgeries. Surgeons who wish to learn the surgical operations of the SHURUI robot should contact Beijing Surgerii Robotics Co., Ltd. to participate in the official training program. Patients who want to participate in the registered clinical trials of the SHURUI robot should contact the official cooperative hospitals of Surgerii and consult with surgeons to determine their suitability for surgery with the SHURUI robot. Both surgeons and patients should carefully understand all information regarding the performance of surgeries by the SHURUI robot and its potential risks.
Beijing Surgerii Robotics Co., Ltd. owns Surgerii®, SHURUI®, and other
trademarks and may not be used without permission.
